Overview: The New England Compounding Center, the company that sits at the center of controversy due to tainted steroid injections that have led to a multi-state outbreak of fungal meningitis, is beginning to face legal repercussions. The company is being scrutinized in several states; of found guilty of violating regulations, NECC officials may face a prison sentence, according to a report in Reuters. Additionally, the first lawsuit over the contaminated products was recently filed.
- NECC is being accused of violating state regulations with regards to the tainted steroid injections linked to the fungal meningitis scandal
- NECC’s license is suspended in Tennessee, which was hit hardest by the scandal
- As of today, the meningitis outbreak has affected 214 people, including 15 deaths
Company Accused of Violating State Regulations
The New England Compounding Center has been feeling the pressure since the company’s tainted injections of methylprednisolone acetate were implicated in a deadly meningitis outbreak that affects 23 states. The company is being investigated in several states, including Michigan, Massachusetts, Indiana, Minnesota, Ohio and Tennessee. So far, Michigan and Massachussetts have accused the company of violating state regulations. Michigan Attorney General Bill Schuette told Reuters that, “(NECC’s) pharmacy license did not allow it to ship large quantities for general use,” NECC officials may face a prison sentence if found guilty of the charges.
Tennessee has been affected the most by the outbreak, with 53 patients affected, including six deaths. The Pharmacy board of Tennessee has recently accepted the company’s offer to have its license suspended in the state. NECC has already surrendered its license in Massachusetts, where it is headquartered.
Other NECC Products Questioned
The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) have advised against using any products manufactured by the company, and NECC has since recalled all of its products.
On Monday, the FDA released a statement about the scandal, warning that another one of the company’s products may be implicated. The agency said that one patient with possible meningitis received an injection of triamcinolone acetonide. Additionally, two patients with a Aspergillus fumigatus infection received a cardioplegic solution during surgery.